ALIM Alimera Sciences Inc
Alimera Sciences Inc is a biopharmaceutical company which is engaged in the research, development, and commercialization of ophthalmic pharmaceuticals.
$6.05
As of 05/25/2022 IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Micro cap
GICS sector: Health Care
Industry: Drug Manufacturers—Specialty &
Index country: USA
Country of incorporation: USA
IPO date: 04/22/2010
Outstanding shares: 7,002,961
Average volume: 27,341
Market cap: $37,815,989
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Quarterly filings:
10-Q
Annual filings:
10-K
Sedol:
Valuation (See tab for details)
PE ratio: -6.19
PB ratio: -12.32
PS ratio: 0.63
Return on equity: 77.64%
Net income %: -11.19%